1 / 4

Kernicterus Market Insights And Epidemiology Forecast

DelveInsightu2019s u201cKernicterus Market Insights, Epidemiology, and Market Forecast-2032u2033 report offers an in-depth understanding of the Kernicterus, historical and forecasted epidemiology as well as the Kernicterus market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. <br>

xmichael
Download Presentation

Kernicterus Market Insights And Epidemiology Forecast

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Kernicterus Market Size Analysis, Growth Opportunities, Pipeline Development Activities, Emerging Therapies, and Epidemiology Forecast High bilirubin levels in a baby's blood can cause kernicterus, a type of brain injury. It can result in hearing loss and athetoid cerebral palsy. Additionally to the eye and dental issues, kernicterus can occasionally result in cerebral difficulties. An uncommon kind of avoidable brain damage called kernicterus can occur in neonates with jaundice. About 60 to 80 percent of infants in the United States suffer from jaundice, a yellowing of the skin and other tissues. Babies experienced it when their blood levels of a substance called bilirubin to rise excessively. This condition typically gets better on its own. Only when the bilirubin level rises to an unhealthy level and is left untreated can jaundice progress to kernicterus and result in permanent brain damage. This condition is also known as BIND or bilirubin-induced neurologic dysfunction. DelveInsight’s “Kernicterus Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Kernicterus, historical and forecasted epidemiology as well as the

  2. Kernicterus market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. Some of the key facts of the Kernicterus Market Report: ● ● Kernicterus only affects about 1 in 44,000 newborns in developed countries The prevalence of Kernicterus was seen in 14% of babies with total bilirubin <25mg/dl and 18% of babies with TSB 25-29 mg/dl The current study's incidence rate of kernicterus (1.3 per 100 000 births) appears to be a little higher than that of earlier population-based studies conducted in high-resource environments ● Request a sample for the Kernicterus Market Report Kernicterus Symptoms The symptoms of Kernicterus include – ● ● ● ● ● Poor Feeding Irritability A high-pitched cry Sleepiness Brief Pauses Epidemiology Segmentation of Kernicterus: ● ● ● ● Prevalent Cases of Kernicterus in the 7MM [2019-2032] Age-Specific Cases of Kernicterus in the 7MM [2019–2032] Gender-Specific Cases of Kernicterus in the 7MM [2019–2032] Diagnosed and Treated Cases of Kernicterus in the 7MM [2019–2032] Kernicterus Market The dynamics of the Kernicterus market are anticipated to change in the coming years owing to the expected launch of emerging therapies such as intralipid (UL), regimen, and others during the forecasted period 2019-2032. Learn more by requesting for sample @ Kernicterus Market Landscape Kernicterus Pipeline Therapies ● ● intralipid (UL) regimen stannsoporfin Kernicterus Pipeline Key Companies ● ● InfaCare Pharmaceuticals Bilimetrix s.r.l. Click here to read more about Kernicterus Market Outlook 2032

  3. Related Reports: Laron Syndrome Pipeline "Laron Syndrome Pipeline Insight, 2022" report by DelveInsight outlines comprehensive insights of present clinical development scenarios and growth prospects across the Laron Syndrome market. A detailed picture of the Laron Syndrome pipeline landscape is provided, which includes the disease overview and Laron Syndrome treatment guidelines. Laron Syndrome Epidemiology DelveInsight's 'Laron Syndrome Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, historical and forecasted Laron Syndrome epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. Diagnostic Imaging Equipment Market Diagnostic Imaging Equipment Market By Product (X-Ray Imaging Systems, Computed Tomography (CT) Scanners, Ultrasound Systems, Magnetic Resonance Imaging (MRI) Systems, Nuclear Imaging Systems, Mammography Systems, And Others), By Application (Cardiology, Oncology, Gastroenterology, Gynecology, And Other Applications), By End-User (Hospitals, Diagnostic Imaging Centres, And Others), by geography is expected to grow at a steady CAGR forecast till 2026 owing to rising technological advancement and increasing prevalence of chronic diseases. Invasive Candidiasis Market "DelveInsight’s ‘Invasive Candidiasis Market Insight, Competitive Landscape and Market Forecast, 2027’ report delivers an in-depth understanding of Invasive Candidiasis and the historical and forecasted Invasive Candidiasis market trends, globally, which comprises of North America, Europe, APAC, and RoW. Sialidosis Market DelveInsight's "Sialidosis Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Sialidosis, historical and forecasted epidemiology as well as the Sialidosis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. Filgrastim Biosimilar Insight DelveInsight’s, “Filgrastim Biosimilar Insight, 2022,” report provides comprehensive insights about 20+ companies and 20+ marketed and pipeline drugs in the Filgrastim Biosimilars landscape. It covers the marketed and pipeline drug profiles, including clinical and non-clinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Pain Management Devices Market Pain Management Devices Market By Type Of Devices (Neuromodulation & Neurostimulation Devices, Analgesic Infusion Pumps [Intrathecal Infusion Pumps and External Infusion Pumps], Ablation Devices

  4. [Radiofrequency Ablation Devices And Cryoablation Devices], And Others), By Application (Neuropathic Pain, Cancer Pain, Facial & Migraine Pain, Musculoskeletal Pain, and Others), By Geography is expected to grow at a steady CAGR Forecast till 2027 Latest Reports by DelveInsight Basal Cell Carcinoma Market | Birch Allergy Market | Bile Duct Neoplasm Market | Gingivitis Market | Lupus Nephritis Market | Severe Hypertriglyceridemia (SHTG) Market | Arthralgia Market | Severe Hypertriglyceridemia (SHTG) Market | Arthralgia Market | Congestive Heart Failure Market | Gingivitis Market | Lupus Nephritis Market | Erythromelalgia Market | AL Amyloidosis Market | Primordial Dwarfism Market | Breast Pumps Market | Hyperuricemia Market | Helicobacter Pylori (H. pylori) Infection Market | AIDS Dementia- Market | Follicular Lymphoma Market | Chronic Pulmonary Hypertension Market | Adrenal Crisis Market | Retinoblastoma Market | Non-Cystic Fibrosis Bronchiectasis Market | Microsatellite Stable Colorectal Cancer Market | Chondrosarcoma Market | Sialidosis Market To know more about our Competitive Services, Click here: Pharma Competitive Intelligence https://www.delveinsight.com/consulting/competitive-intelligence-services

More Related